Grounding the resilience of global biotech supply chains

Published on November 5, 2025

View the Panel above with Wendy Zatylny

Continue reading on website
Other news

GSK – Survey Highlights Gaps in RSV Awareness, Risk Understanding Among Vulnerable Older Canadian Adults

November 5, 2025
Many Canadian adults aged 50+ with certain chronic health conditions underestimate their personal risk of severe RSV illness1 despite a higher chance of serious illness and hospitalization.2,3,4,5Responses also show many Canadians at a higher risk of severe RSV illness are not discussing the virus with their doctor and most have not received the RSV vaccination.Survey highlights urgent need for pu

BIOVECTRA and Revolution Biomanufacturing – Partner to Deliver Integrated mRNA Design and GMP Production Services — Partnership Combines Sequence Design Expertise with End-to-End GMP Manufacturing to Streamline mRNA Development and Scale-up

November 6, 2025
CHARLOTTETOWN, PEI and WORCESTER, MA – November 6, 2025 – BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing’s proprietary platforms for optimizing untranslated regions (UTRs) and codon usage to enhance mRNA stability and translational efficiency. This partnership provides